NCT01824966
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
- Locations
-
- University Hospital Leuven; Dept. of Thoracic Surgery Leuven, Belgium
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
434 public trials
103 recruiting studies
Adenocarcinoma trial results
NCT00106353
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site Chicago, Illinois, United States
- Pfizer Investigational Site Indianapolis, Indiana, United States
NCT01579721
- Conditions
- Adenocarcinoma, Carcinoma, Colorectal Neoplasms, +13 more
- Locations
-
- Department of Gastroentestinal Surgery, Hvidovre Hospital Hvidovre, Denmark
NCT00597506
- Conditions
- Adenocarcinoma, Carcinoma, Colorectal Adenocarcinoma, +3 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT01262482
- Conditions
- Adenocarcinoma, Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment), Carcinoma, +7 more
- Locations
-
- Hospital Clinic de Barcelona Barcelona, Spain
- Hospital Sant Pau Barcelona, Spain
- H. Josep Trueta Girona, Spain
- Centro Oncológico M.D. Anderson Spain Madrid, Spain
NCT00844675
- Conditions
- Adenocarcinoma, Adenocarcinoma, Tubular, Carcinoma, +10 more
- Locations
-
- Catholic University, Gangnam St. Mary's Hospital Seoul, Ban-po Dong 505, South Korea
Completed
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma
NCT01161186
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
Completed
Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
NCT00292864
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +3 more
- Locations
-
- Premiere Oncology of Arizona Scottsdale, Arizona, United States
- University of California Davis Medical Center Davis, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT00226005
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasm, +7 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- University of Arizona/Arizona Cancer Center Tucson, Arizona, United States
- Tower Hematology Oncology Medical Group Beverly Hills, California, United States
- Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Baltimore, Maryland, United States
NCT00083278
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +8 more
- Locations
-
- Sharp Clinical Oncology Research San Diego, California, United States
- Wishard Health Services Indianapolis, Indiana, United States
- Section of Hematology/Oncology, Indiana Cancer Pavilion Indianapolis, Indiana, United States
- Indiana University, Clarian Health Partners Indianapolis, Indiana, United States